These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21922151)

  • 21. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis.
    Tamiolakis D; Simopoulos C; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Koutsougeras G; Alexiadis G; Menegaki M; Papadopoulos N
    Clin Exp Med; 2005 Oct; 5(3):106-11. PubMed ID: 16284732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibody signature in human ductal pancreatic adenocarcinoma.
    Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
    J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
    Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
    J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.
    Tsiambas E; Kravvaritis C; Tsounis D; Salemis NS; Niotis A; Niotis TH; Rigopoulos DN; Karameris A; Athanasiou AE; Patsouris E; Karakitsos P
    J BUON; 2010; 15(1):94-100. PubMed ID: 20414934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
    Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
    Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
    Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue.
    Bünger S; Barow M; Thorns C; Freitag-Wolf S; Danner S; Tiede S; Pries R; Görg S; Bruch HP; Roblick UJ; Kruse C; Habermann JK
    Eur Surg Res; 2012; 49(2):88-98. PubMed ID: 22948659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
    Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
    Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.
    Askan G; Sahin IH; Chou JF; Yavas A; Capanu M; Iacobuzio-Donahue CA; Basturk O; O'Reilly EM
    BMC Cancer; 2021 Apr; 21(1):385. PubMed ID: 33836674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
    Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
    Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
    Yamamoto S; Nakamori S; Tsujie M; Takahashi Y; Nagano H; Dono K; Umeshita K; Sakon M; Tomita Y; Hoshida Y; Aozasa K; Kohno K; Monden M
    Pathobiology; 2004; 71(1):12-8. PubMed ID: 14555840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
    Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
    Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
    Hong X; Michalski CW; Kong B; Zhang W; Raggi MC; Sauliunaite D; De Oliveira T; Friess H; Kleeff J
    J Surg Oncol; 2010 Jun; 101(7):564-9. PubMed ID: 20461761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
    Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
    Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
    Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
    Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.